RETA
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
RETA
Delisted
RETA was delisted on the 25th of September, 2023.
158 hedge funds and large institutions have $1.66B invested in Reata Pharmaceuticals, Inc. Class A Common Stock in 2019 Q2 according to their latest regulatory filings, with 26 funds opening new positions, 59 increasing their positions, 47 reducing their positions, and 23 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
158
Holders Change
+1
Holders Change %
+0.64%
% of All Funds
3.44%
Holding in Top 10
5
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.11%
New
26
Increased
59
Reduced
47
Closed
23
Calls
$12.6M
Puts
$31.7M
Net Calls
-$19.1M
Net Calls Change
-$21.9M
Top Buyers
Top Sellers
| 1 |
DM
Deerfield Management
New York
|
$18.6M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
$4.6M |
| 3 |
Millennium Management
New York
|
$39.9M |
| 4 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
$4.48M |
| 5 |
PM
Prosight Management
Dallas,
Texas
|
$11.8M |
